Fuzhou Maixin Biotech Co., Ltd. (doing business as MXB Biotechnologies), part of Beijing Strong Biotechnologies, Inc., is a Chinese company located in Fuzhou. The firm engages in production, research & development and sales and focus on tissue-based diagnostics specifically IHC antibodies, reagents and the automation of IHC and ISH. It was founded in 1993. Xiao Ya Wang is the current CEO of the firm. Fuzhou Maixin Biotech Co. Ltd. acquired Fuzhou Maixin Biotech Co., Ltd. on September 30, 2020 for $255.21 million.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Promega Contributing to the prevention, healing and more. Founded in 1978, which began with the production of enzymes for research, has evolved into a catalog of over 2,000 products for a wide range of applications, including basic research, drug discovery, forensics, paternity testing and diagnosis clinician.

Sense Proteomic is discovers and commercializes autoantibody biomarkers for cancer and autoimmune diseases. It offers Kinome 2.0plus that is used by the pharmaceutical industry to screen kinase leads against human kinases. The company also provides biomarker panels for prostate cancer and lupus.

Zycos Inc. used to develop and market anticancer pharmaceutical and medical therapies and products. The company used to focus on drug discovery before redirecting toward drug development. Its core technology used to provide a direct method for the treatment of chronic viral infections and cancer as well as single product that work on all autoimmune diseases. Zycos was founded in 1996 and located in Lexington, MA

Sengenics is a functional proteomics company that leverages its patented KREX™ technology for production of full-length, correctly folded and functional proteins. KREX™ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge. Jonathan is the CSO of Sengenics. The key application of KREX™ is the discovery of autoantibody biomarkers for two core medical use cases. Firstly, stratification of patients undergoing treatment with autoimmune or cancer drugs into responders, non-responders and those that may exhibit severe immune-related adverse events. Secondly, identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions years before conventional diagnostic tests.

Zyomyx has a unique expertise in and passion for tackling difficult “outside-the-box” problems. Highly user-friendly, instrument-free point-of-care tests need to be designed with an advanced level of cartridge engineering and reagent stability, and aligned with aggressive cost targets. Zyomyx specializes in exactly these demanding product requirements. Our immediate focus is an advanced, but simple to use and inexpensive CD4 T-cell point-of-care test that will be launched globally and configured to especially meet the demanding specifications for use in low and middle income countries.

Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA.

The Howard Hughes Medical Institute is a non-profit medical research organization that aims to advance biomedical research and science education. It seeks to strengthen education in biology and related sciences from elementary school to graduate studies by introducing science education programs. The institute’s offerings include BioInteractive: free resources for science teachers and students, including animations, short films, and apps; HHMI Bulletin: a science magazine that explores biomedical research through in-depth features, news, and perspectives; Janelia Research Campus: a research center where scientists pursue challenging problems in a collaborative setting; and Tangled Bank Studios: a production company that creates science films for broadcast, cinema, and digital media. The Howard Hughes Medical Institute was founded by Howard Hughes in 1953 and is based in Chevy Chase, Maryland.

Kangma (Shanghai) Biotechnology Co., Ltd., established on 2015-10-20, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of bio-based materials;Instrument sales;Sales of bio-based materials;Sales of Class I Medical Devices;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Nanjing Novizan Biotechnology Co., Ltd., established on 2012-03-16, Business scope includes biological reagents,Enzyme reagent research and development,Production,Sales,Technical Consulting and Technical Services;Biochemical reagents and consumables,Electrical Equipment,electronics sales;Self-operated and agent import and export business of various commodities and technologies(Except where the state restricts enterprises to operate or prohibits the import and export of commodities and technologies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Experimental analysis instrument sales;Manufacturing of experimental analysis instruments;Mechanical equipment research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Part of CellCarta Biosciences, Inc., PPD Biomarker Discovery Sciences LLC is an American company located in San Diego, CA, that provides global contract and consulting research and development services for the pharmaceutical and biotechnology industries. On December 31, 2009 CellCarta Biosciences, Inc. acquired PPD Biomarker Discovery Sciences LLC from Pharmaceutical Product Development LLC for $0.10 million.

The Public Health Research Institute (PHRI) was founded in 1942 by New York City's mayor, Fiorello La Guardia, who appointed David M. Heyman to lead it as an independent not-for-profit research organization. In the late 1980s it was referred to as Public Health Research Institute - New York In 2002, they moved to Newark, New Jersey. PHRI became part of the New Jersey Medical School in 2006 and since 2013 it has been part at Rutgers University.

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. It operates through the BioScience and BioIndustrial segments. The BioScience segment works on enzymes and performance microorganisms; and collaborates with industrial partners. The BioIndustrial segment deals with the bioproduct and cosmetics businesses. The company was founded by Holger Zinke, Jüngen Eck, and Hans Günter Gassen on September 22, 1993 and is headquartered in Zwingenberg, Germany.

Pierce Chemical manufactures and distributes embalming fluids.